Bordetella pertussis Antikörper
Kurzübersicht für Bordetella pertussis Antikörper (ABIN2859505)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Protein A chromatography
-
Reinheit
- > 90 %.
-
Immunogen
- Bordetella pertussis N-lauroyl sarcosine membrane extract
-
Isotyp
- IgG3
-
-
-
-
Applikationshinweise
-
Suitable for use in ELISA, IFA and Western blot.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.1 mg/mL (OD280 nm, E0.1% = 1.4)
-
Buffer
- 0.01 M PBS, pH 7.2, containing 0.09 % sodium azide as preservative.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Bordetella pertussis
-
Substanzklasse
- Bacteria
-
Hintergrund
- Bordetella pertussis is an aerobic, gram negative coccobacilli. It causes whooping cough (pertussis), an acute respiratory infection marked by severe, spasmodic coughing episodes during the paroxysmal phase. Leukocytosis with lymphocytosis is also common during this phase of the illness. Dangerous complications are bronchopneumonia and acute encephalopathy. It produces a number of virulence factors, including pertussis toxin, adenylate cyclase toxin, filamentous hemagglutinin, and hemolysin. Agglutinogens and other outer membrane proteins are important antigens.
Target
-